Adriamycin (Doxorubicin) was perfused through the ventriculo-cisternal (VC) and ventriculo-lumbar (VL) spaces of Rhesus monkeys at inflow concentrations ranging from 1.5 to 100 μg/ml at an average inflow rate of 128 μl/min for 190 min. Animals died or became moribund within 10 days following perfusion of Adriamycin within the range of inflow concentrations of 6.0 to 100 μg/ml. General neurotoxicity consisted of general body weakness, tremors, severe to slight hypokinesia (especially of the hindlimbs), and signs of excitation, nervousness, or depression after a perfusion. Other adverse responses were a significant decrease in water and food intake, mydriasis, and loss of the wink reflex in one or both eyes. With the exception of isolated instances, only trasient minor changes occurred in heart rate and rhythm, respiratory rate, body temperature, cortical EEG, opening ventricular pressure, CSF formation rate, and inulin clearance. Conditioned avoidance behavior was not significantly affected in otherwise normal animals; although, at times, motor deficits of the arms may have interfered with performance. In the brains of three monkeys perfused at 100, 12.5, or 6.0 μg/ml, there was a distinctive necrotizing angiopathy that was noninflammatory and for which it is difficult to find an exact parallel in human pathology. In view of the particular findings shown in this study, it is not recommended that this drug be administered intrathecally in man.
Read full abstract